Perrigo (PRGO) Stock Plunges to 52-Week Low as Outlook Slashed – What Investors Need to Know
Perrigo Company plc is a consumer healthcare and self-care products company with over a century of history in the OTC medicine space Perrigo. Now domiciled in Dublin, Ireland, Perrigo’s business spans a broad range of non-prescription health products. The company produces store-brand OTC medicines as well as its own branded products in categories like cough & cold remedies, pain relief, digestive health, vitamins, infant formula, and dermatology care Patsnap Patsnap. Perrigo’s unique business model leverages its cash-generating store-brand portfolio to fund the growth of its branded offerings – which include names like Opill®, Mederma® skincare, and allergy treatments like Nasonex Perrigo Patsnap. In essence, Perrigo is positioned as a “pure-play” self-care/OTC company, focusing on products that consumers can buy without a prescription to manage their health. Its operations are divided into two segments: Consumer Self-Care Americas and Consumer Self-Care International Perrigo Perrigo. CSCA covers the U.S. and related markets, while CSCI serves Europe and other regions with a mix of regional brands and global products. This dual segment structure allows Perrigo to adapt to local market needs and compete both with generic manufacturers and with big-brand pharmaceutical companies in the OTC arena Patsnap Patsnap.
